Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by Evelo Biosciences, Inc. Evelo Biosciences Announces Top-Line Results From its Phase 2 Clinical Study with EDP2939 in Moderate Psoriasis October 17, 2023 From Evelo Biosciences, Inc. Via GlobeNewswire Tickers EVLO Evelo Biosciences Announces Second Quarter Financial Results and Recent Business Highlights August 14, 2023 From Evelo Biosciences, Inc. Via GlobeNewswire Tickers EVLO Evelo Biosciences Closes $25.5 Million Private Placement July 12, 2023 From Evelo Biosciences, Inc. Via GlobeNewswire Tickers EVLO Evelo Biosciences Announces $25.5 Million Private Placement July 10, 2023 From Evelo Biosciences, Inc. Via GlobeNewswire Tickers EVLO Evelo Biosciences Announces Reverse Stock Split Effective June 29, 2023 From Evelo Biosciences, Inc. Via GlobeNewswire Tickers EVLO Evelo Biosciences Provides Clinical Updates April 26, 2023 From Evelo Biosciences, Inc. Via GlobeNewswire Tickers EVLO Evelo Biosciences Announces Fourth Quarter and Full Year 2022 Financial Results and Business Highlights March 16, 2023 From Evelo Biosciences, Inc. Via GlobeNewswire Tickers EVLO Evelo Biosciences to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, March 16, 2023 March 09, 2023 From Evelo Biosciences, Inc. Via GlobeNewswire Tickers EVLO Evelo Biosciences to Participate in the Cowen 43rd Annual Health Care Conference March 01, 2023 From Evelo Biosciences, Inc. Via GlobeNewswire Tickers EVLO Evelo Biosciences Reports that EDP2939, its First Oral Extracellular Vesicle Product Candidate, Commenced Dosing in a Phase 2 Psoriasis Trial February 27, 2023 From Evelo Biosciences, Inc. Via GlobeNewswire Tickers EVLO Evelo Biosciences Provides Clinical and Business Updates February 01, 2023 From Evelo Biosciences, Inc. Via GlobeNewswire Tickers EVLO Evelo Biosciences Announces $45 Million Loan Agreement with Horizon Technology Finance Corporation to Refinance Existing Debt December 16, 2022 From Evelo Biosciences, Inc. Via GlobeNewswire Tickers EVLO HRZN Evelo Biosciences Announces Publication of Scientific Basis for SINTAX Medicines in Frontiers in Immunology November 15, 2022 From Evelo Biosciences, Inc. Via GlobeNewswire Tickers EVLO Evelo Biosciences Reports Third Quarter 2022 Financial Results and Business Highlights November 14, 2022 From Evelo Biosciences, Inc. Via GlobeNewswire Tickers EVLO Evelo Biosciences to Present at the 2022 Jefferies London Healthcare Conference November 08, 2022 From Evelo Biosciences, Inc. Via GlobeNewswire Tickers EVLO Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.